Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
67
RGA Quote, Financials, Valuation and Earnings
Last price:
$197.72
Seasonality move
:
2.92%
Day range:
$190.96 - $194.67
52-week range:
$159.25 - $233.81
Dividend yield:
1.84%
P/E ratio:
16.37x
P/S ratio:
0.62x
P/B ratio:
1.12x
Volume:
439.7K
Avg. volume:
351K
1-year change:
-9.32%
Market cap:
$12.8B
Revenue:
$22B
EPS (TTM):
$11.85
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $14.6B | $16.1B | $15.9B | $18.3B | $22B | |
| Revenue Growth (YoY) | 2.8% | 10.4% | -1.38% | 15.64% | 19.94% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $360M | $449M | $527M | $372M | $593M | |
| Operating Expenses | $816M | $936M | $1B | $1.1B | $1.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $187M | $139M | $191M | $257M | $304M | |
| EBT. Incl. Unusual Items | $553M | $1.4B | $718M | $1.2B | $980M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $138M | $215M | $197M | $251M | $256M | |
| Net Income to Company | $415M | $1.2B | $517M | $902M | $717M | |
| Minority Interest in Earnings | -- | -- | -$4M | -$7M | -$7M | |
| Net Income to Common Excl Extra Items | $415M | $1.2B | $517M | $902M | $717M | |
| Basic EPS (Cont. Ops) | $6.35 | $17.26 | $7.73 | $13.60 | $10.90 | |
| Diluted EPS (Cont. Ops) | $6.31 | $17.13 | $7.64 | $13.44 | $10.73 | |
| Weighted Average Basic Share | $65.4M | $67.8M | $66.9M | $66.3M | $65.8M | |
| Weighted Average Diluted Share | $65.8M | $68.3M | $67.7M | $67.1M | $66.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $723M | $1.5B | $909M | $1.4B | $1.3B | |
| Revenue (Reported) | $14.6B | $16.1B | $15.9B | $18.3B | $22B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $723M | $1.5B | $909M | $1.4B | $1.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | $3.8B | $4.2B | $6.3B | $5.3B | |
| Revenue Growth (YoY) | 23.53% | -5.1% | 11.74% | 50.82% | -16.67% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $91M | $91M | $87M | $149M | $88M | |
| Operating Expenses | $214M | $227M | $250M | $283M | $300M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $48M | $43M | $53M | $68M | $80M | |
| EBT. Incl. Unusual Items | $186M | $267M | $351M | $272M | $369M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $47M | $70M | $98M | $60M | $81M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -$1M | -$2M | -$2M | |
| Net Income to Common Excl Extra Items | $139M | $197M | $252M | $210M | $286M | |
| Basic EPS (Cont. Ops) | $2.04 | $2.93 | $3.77 | $3.20 | $4.33 | |
| Diluted EPS (Cont. Ops) | $2.03 | $2.91 | $3.72 | $3.16 | $4.27 | |
| Weighted Average Basic Share | $68M | $67M | $67M | $66M | $66M | |
| Weighted Average Diluted Share | $68M | $68M | $68M | $67M | $67M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $231M | $309M | $404M | $340M | $449M | |
| Revenue (Reported) | $4B | $3.8B | $4.2B | $6.3B | $5.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $231M | $309M | $404M | $340M | $449M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $15.3B | $16B | $16.3B | $20.5B | $20.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $375M | $449M | $523M | $434M | $532M | |
| Operating Expenses | $835M | $949M | $1B | $1.1B | $1.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $188M | $134M | $201M | $272M | $316M | |
| EBT. Incl. Unusual Items | $835M | $1.5B | $802M | $1.1B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $193M | $238M | $225M | $213M | $277M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -$5M | -$8M | -$7M | |
| Net Income to Common Excl Extra Items | $642M | $1.2B | $572M | $860M | $793M | |
| Basic EPS (Cont. Ops) | $9.61 | $9.99 | $8.57 | $13.03 | $12.03 | |
| Diluted EPS (Cont. Ops) | $9.57 | $9.91 | $8.44 | $12.87 | $11.85 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1B | $1.6B | $1B | $1.4B | $1.4B | |
| Revenue (Reported) | $15.3B | $16B | $16.3B | $20.5B | $20.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1B | $1.6B | $1B | $1.4B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | $3.8B | $4.2B | $6.3B | $5.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $91M | $91M | $87M | $149M | $88M | |
| Operating Expenses | $214M | $227M | $250M | $283M | $300M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $48M | $43M | $53M | $68M | $80M | |
| EBT. Incl. Unusual Items | $186M | $267M | $351M | $272M | $369M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $47M | $70M | $98M | $60M | $81M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -$1M | -$2M | -$2M | |
| Net Income to Common Excl Extra Items | $139M | $197M | $252M | $210M | $286M | |
| Basic EPS (Cont. Ops) | $2.04 | $2.93 | $3.77 | $3.20 | $4.33 | |
| Diluted EPS (Cont. Ops) | $2.03 | $2.91 | $3.72 | $3.16 | $4.27 | |
| Weighted Average Basic Share | $68M | $67M | $67M | $66M | $66M | |
| Weighted Average Diluted Share | $68M | $68M | $68M | $67M | $67M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $231M | $309M | $404M | $340M | $449M | |
| Revenue (Reported) | $4B | $3.8B | $4.2B | $6.3B | $5.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $231M | $309M | $404M | $340M | $449M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.4B | $2.9B | $2.9B | $3B | $3.3B | |
| Short Term Investments | $57B | $60.8B | $53.1B | $60.7B | $10.7B | |
| Accounts Receivable, Net | $983M | $2.6B | $2.7B | $5.4B | $5.5B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $61.4B | $66.4B | $58.8B | $69.2B | $19.7B | |
| Property Plant And Equipment | $260M | $270M | $270M | $279M | $325M | |
| Long-Term Investments | $57.1B | $63B | $55.5B | $63.5B | $81.3B | |
| Goodwill | $7M | $7M | -- | -- | -- | |
| Other Intangibles | $206M | $186M | $164M | $154M | $133M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $84.7B | $92.2B | $84.9B | $97.6B | $118.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $400M | $400M | $1.5B | $4.5B | $5B | |
| Long-Term Debt | $3.6B | $3.8B | $4B | $4.4B | $5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $70.3B | $79.2B | $77.7B | $88.5B | $107.8B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | $5.4B | $3.6B | -$1.9B | -$369M | $849M | |
| Common Equity | $14.4B | $13B | $7.1B | $9.1B | $10.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $90M | $90M | $90M | |
| Total Equity | $14.4B | $13B | $7.2B | $9.2B | $10.9B | |
| Total Liabilities and Equity | $84.7B | $92.2B | $84.9B | $97.6B | $118.7B | |
| Cash and Short Terms | $60.4B | $63.8B | $56B | $63.7B | $14.1B | |
| Total Debt | $4B | $3.8B | $4B | $4.4B | $5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.1B | $2.7B | $3.3B | $5.9B | $5.2B | |
| Short Term Investments | $56.6B | $58.2B | $56.3B | $9.6B | $11.9B | |
| Accounts Receivable, Net | $1.1B | $2.6B | $2.7B | $5.3B | $5.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $60.8B | $63.5B | $62.3B | $20.9B | $22.4B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $56.7B | $58.4B | $58.9B | $69B | $88.3B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $84.8B | $89.8B | $89.1B | $106B | $128.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $4.4B | $4.9B | |
| Long-Term Debt | $3.9B | $3.8B | $4.5B | $4.4B | $5.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $72.7B | $80.5B | $81.4B | $96.4B | $116.7B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | $3B | -$55M | -$1.5B | -$125M | $1.2B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $90M | $90M | $90M | $90M | |
| Total Equity | $12.1B | $9.3B | $7.7B | $9.6B | $11.5B | |
| Total Liabilities and Equity | $84.8B | $89.8B | $89.1B | $106B | $128.2B | |
| Cash and Short Terms | $59.7B | $60.9B | $59.6B | $15.5B | $17B | |
| Total Debt | $3.9B | $3.8B | $4.5B | $4.4B | $5.7B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $415M | $1.2B | $517M | $902M | $717M | |
| Depreciation & Amoritzation | $49M | $43M | $38M | $41M | $46M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $47M | $14M | -$188M | -$746M | -$166M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.3B | $4.2B | $1.3B | $4B | $9.4B | |
| Capital Expenditures | $28M | -- | -- | -- | -- | |
| Cash Acquisitions | -$173M | -$287M | $17M | -$77M | -$320M | |
| Cash From Investing | -$2.7B | -$4.6B | -$5.7B | -$4.1B | -$12.5B | |
| Dividends Paid (Ex Special Dividend) | -$182M | -$194M | -$205M | -$219M | -$229M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $598M | $494M | $690M | $890M | $640M | |
| Long-Term Debt Repaid | -$217M | -$611M | -$584M | -$428M | -$28M | |
| Repurchase of Common Stock | -$163M | -$99M | -$81M | -$227M | -$27M | |
| Other Financing Activities | $768M | $399M | $4.4B | -$541M | $3.1B | |
| Cash From Financing | $1.3B | $20M | $4.4B | $78M | $3.7B | |
| Beginning Cash (CF) | $1.4B | $3.4B | $2.9B | $2.9B | $3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.9B | -$426M | $91M | $56M | $486M | |
| Ending Cash (CF) | $3.4B | $2.9B | $2.9B | $3B | $3.3B | |
| Levered Free Cash Flow | $3.3B | $4.2B | $1.3B | $4B | $9.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.4B | $163M | $1.6B | $5.7B | $1.4B | |
| Capital Expenditures | $4M | $6M | -- | -- | -- | |
| Cash Acquisitions | -- | $230M | -$26M | -$63M | -$187M | |
| Cash From Investing | -$2.5B | -$2.2B | -$1.7B | -$3.7B | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$48M | -$49M | -$53M | -$56M | -$59M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $494M | -- | $691M | |
| Long-Term Debt Repaid | -$43M | -$15M | -$1M | -$1M | -$1M | |
| Repurchase of Common Stock | -$1M | -$27M | -$67M | -$16M | -$38M | |
| Other Financing Activities | -$26M | $2B | $107M | $1.2B | $1.5B | |
| Cash From Financing | -$143M | $1.9B | $497M | $1B | $2.1B | |
| Beginning Cash (CF) | $3.4B | $2.9B | $2.9B | $3B | $3.3B | |
| Foreign Exchange Rate Adjustment | -$17M | -$21M | $1M | -$56M | $24M | |
| Additions / Reductions | -$269M | -$218M | $366M | $3B | $1.8B | |
| Ending Cash (CF) | $3.1B | $2.7B | $3.3B | $5.9B | $5.2B | |
| Levered Free Cash Flow | $2.4B | $157M | $1.6B | $5.7B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.5B | $2B | $2.8B | $8.2B | $5.1B | |
| Capital Expenditures | $26M | $2M | -$6M | -- | -- | |
| Cash Acquisitions | -$173M | -$57M | -$239M | -$114M | -$444M | |
| Cash From Investing | -$4.1B | -$4.4B | -$5.2B | -$6.1B | -$10.5B | |
| Dividends Paid (Ex Special Dividend) | -$186M | -$195M | -$209M | -$222M | -$232M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $1.2B | $396M | $1.3B | |
| Long-Term Debt Repaid | -$240M | -$583M | -$570M | -$428M | -$28M | |
| Repurchase of Common Stock | -$8M | -$125M | -$121M | -$176M | -$49M | |
| Other Financing Activities | $267M | $2.4B | $2.5B | $575M | $3.4B | |
| Cash From Financing | $804M | $2B | $3.1B | $586M | $4.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $209M | -$375M | $675M | $2.7B | -$734M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.5B | $2B | $2.8B | $8.2B | $5.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.4B | $163M | $1.6B | $5.7B | $1.4B | |
| Capital Expenditures | $4M | $6M | -- | -- | -- | |
| Cash Acquisitions | -- | $230M | -$26M | -$63M | -$187M | |
| Cash From Investing | -$2.5B | -$2.2B | -$1.7B | -$3.7B | -$1.7B | |
| Dividends Paid (Ex Special Dividend) | -$48M | -$49M | -$53M | -$56M | -$59M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $494M | -- | $691M | |
| Long-Term Debt Repaid | -$43M | -$15M | -$1M | -$1M | -$1M | |
| Repurchase of Common Stock | -$1M | -$27M | -$67M | -$16M | -$38M | |
| Other Financing Activities | -$26M | $2B | $107M | $1.2B | $1.5B | |
| Cash From Financing | -$143M | $1.9B | $497M | $1B | $2.1B | |
| Beginning Cash (CF) | $3.4B | $2.9B | $2.9B | $3B | $3.3B | |
| Foreign Exchange Rate Adjustment | -$17M | -$21M | $1M | -$56M | $24M | |
| Additions / Reductions | -$269M | -$218M | $366M | $3B | $1.8B | |
| Ending Cash (CF) | $3.1B | $2.7B | $3.3B | $5.9B | $5.2B | |
| Levered Free Cash Flow | $2.4B | $157M | $1.6B | $5.7B | $1.4B | |
Get RGA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RGA
Sector
P/E ratio
16.37x
12.18x
PEG ratio
0.59x
0.40x
P/B ratio
1.12x
1.10x
Price / LTM sales
0.62x
2.66x
Growth Metrics
RGA
Sector
Revenue growth
-16.67%
5.1%
Earnings growth
35.13%
2.61%
Revenue (5-year growth)
9.2%
5.17%
Earnings forecast
$5.55
$0.61
Profitability
RGA
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
5.06%
5.2%
Return on assets
0.68%
0.97%
Return on equity
7.48%
9.24%
Earnings Date
Last Earnings Date
May
1
Next Earnings Date
Jul
31
Estimated Next Earnings Date
Jul
31
Balance Sheet
RGA
Sector
Total cash
$17B
$452M
Short term investments
$10.7B
$220.9M
Total assets
$118.7B
$3.8B
Long term debt
$5.7B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
